Cited by 591Pancreatic and Hepatic Oncology ResearchCancer Genomics and DiagnosticsBreast Cancer Treatment Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Puleo, Francesco, Nicolle, Rémy, Blum, Yuna, Cros, Jérôme, Marisa, Laetitia, Demetter, Pieter, Quertinmont, Eric, Svrcek, Magali, Elarouci, Nabila, Iovanna, Juan, Franchimont, Denis, Verset, Laurine, Galdon, Maria Gomez, Devière, Jacques, de Reyniès, Aurélien, Laurent-Puig, Pierre, Van Laethem, Jean-Luc, Bachet, Jean-Baptiste, Maréchal, Raphaël·2018·Gastroenterology

DOI 10.1053/j.gastro.2018.08.033

Open this paper in CoChat — free account

Abstract

Background & aims Genomic studies have revealed subtypes of pancreatic ductal adenocarcinoma (PDA) based on their molecular features, but different studies have reported different classification systems. It is a challenge to obtain high-quality, freshly frozen tissue for clinical analysis and determination of PDA subtypes. We aimed to redefine subtypes of PDA using a large number of formalin-fixed and paraffin-embedded PDA samples, which are more amenable to routine clinical evaluation.Methods We collected PDA samples from 309 consecutive patients who underwent surgery from September 1996 through December 2010 at 4 academic hospitals in Europe; nontumor tissue samples were not included. Samples were formalin fixed and paraffin embedded. DNA and RNA were isolated; gene expression, targeted DNA sequencing, and immunohistochemical analyses were performed. We used independent component analysis to deconvolute normal, tumor, and microenvironment transcriptome patterns in samples. We devised classification systems from an unsupervised analysis using a consensus clustering approach of our data set after removing normal contamination components. We associated subtypes with overall survival and disease-free survival of patients using Cox proportional hazards regression with estimation of hazard ratios and 95% confidence interval. We used The Cancer Genome Consortium and International Cancer Genome Consortium PDA data sets as validation cohorts.Results We validated the previously reported basal-like and classical tumor-specific subtypes of PDAs. We identified features of the PDA, including microenvironment gene expression patterns, that allowed tumors to be categorized into 5 subtypes, called pure basal like, stroma activated, desmoplastic, pure classical, and immune classical. These PDA subtypes have features of cancer cells and immune cells that could be targeted by pharmacologic agents. Tumor subtypes were associated with patient outcomes, based on analysis of our data set and the International Cancer Genome Consortium and The Cancer Genome Consortium PDA data sets. We also observed an exocrine signal associated with acinar cell contamination (from pancreatic tissue).Conclusions We identified a classification system based on gene expression analysis of formalin-fixed PDA samples. We identified 5 PDA subtypes, based on features of cancer cells and the tumor microenvironment. This system might be used to select therapies and predict patient outcomes. We found evidence that the previously reported exocrine-like (called ADEX) tumor subtype resulted from contamination with pancreatic acinar cells. ArrayExpress accession number: E-MTAB-6134.

Integrity signals

Registry

Crossref · 10.1053/j.gastro.2018.08.033

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cancer Statistics, 2017.
Siegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Inferring tumour purity and stromal and immune cell admixture from expression data
Yoshihara, K., Shahmoradgoli, M., Martínez, E., Vegesna, R., Kim, H., Torres-Garcia, W., Treviño, V., Shen, H., Laird, P. W., Levine, D. A., et al. (2013) · Nature Communications · doi:10.1038/ncomms3612 · Cited by 9,778
Projecting Cancer Incidence and Deaths to 2030: The Unexpected Burden of Thyroid, Liver, and Pancreas Cancers in the United States
Rahib, L., Smith, B. D., Aizenberg, R., Rosenzweig, A. B., Fleshman, J. M., & Matrisian, L. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0155 · Cited by 7,094
Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade
Le, D. T., Durham, J. N., Smith, K. N., Wang, H., Bartlett, B. R., Aulakh, L. K., Lu, S., Kemberling, H., Wilt, C., Luber, B. S., et al. (2017) · Science · doi:10.1126/science.aan6733 · Cited by 6,645
The <tt>sva</tt> package for removing batch effects and other unwanted variation in high-throughput experiments
Leek, J. T., Johnson, W. E., Parker, H. S., Jaffe, A. E., & Storey, J. D. (2012) · Bioinformatics · doi:10.1093/bioinformatics/bts034 · Cited by 6,231
ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking
Wilkerson, M. D., & Hayes, D. N. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btq170 · Cited by 5,645
The consensus molecular subtypes of colorectal cancer
Guinney, J., Dienstmann, R., Wang, X., de Reyniès, A., Schlicker, A., Soneson, C., Marisa, L., Roepman, P., Nyamundanda, G., Angelino, P., et al. (2015) · Nature Medicine · doi:10.1038/nm.3967 · Cited by 5,170
Self-citation
Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression
Becht, É., Giraldo, N. A., Lacroix, L., Buttard, B., Elarouci, N., Petitprez, F., Sèlves, J., Laurent‐Puig, P., Sautès‐Fridman, C., Fridman, W. H., et al. (2016) · Genome biology · doi:10.1186/s13059-016-1070-5 · Cited by 3,677
Self-citation
Genomic analyses identify molecular subtypes of pancreatic cancer
Bailey, P., Chang, D. K., Nones, K., Johns, A. L., Patch, A.-M., Gingras, M.-C., Miller, D. K., Christ, A. N., Bruxner, T. J. C., Quinn, M. C., et al. (2016) · Nature · doi:10.1038/nature16965 · Cited by 3,621
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170

Flagged first, then by citations

Show all 34 references

Research works printed but not linked: 3

Nicolle, 2017, Pancreatic adenocarcinoma therapeutic targets revealed by tumor-stroma cross-talk analyses in patient-derived xenografts, Cell Rep, 21, 2458, 10.1016/j.celrep.2017.11.003 · DOI
Bailey, 2016, Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, 531, 47, 10.1038/nature16965 · DOI · Paper page
Moffitt, 2015, Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma, Nat Genet, 47, 1168, 10.1038/ng.3398 · DOI · Paper page

Sorted by citations

Items 401–500 of 591

Multi-Omics Profiling Reveals Glycerolipid Metabolism-Associated Molecular Subtypes and Identifies ALDH2 as a Prognostic Biomarker in Pancreatic Cancer
Liu, J., Ma, S., Deng, D., Yang, Y., Li, J., Zhang, Y., Yin, P., & Shang, D. (2025) · Metabolites · doi:10.3390/metabo15030207 · Cited by 3
Unlocking the Genetic Secrets of Pancreatic Cancer: KRAS Allelic Imbalances in Tumor Evolution
Liaki, V., Rosas-Pérez, B., & Guerra, C. E. (2025) · Cancers · doi:10.3390/cancers17071226 · Cited by 2
Role of Endoscopic Ultrasound (EUS) in the Era of Precision Medicine for Pancreatic Cancer Through Next-Generation Sequencing Technology
Peserico, G., Stornello, C., Tessari, M., Scapinello, A., Curtarello, M., Gruppo, M., Simoni, O. D., & Fantin, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178444 · Cited by 2
Development of a consensus molecular classifier for pancreatic ductal adenocarcinoma
Villoslada-Blanco, P., Alonso, L., Sabroso‐Lasa, S., Maquedano, M., Estudillo, L., Real, F. X., de Maturana, E. L., & Malats, N. (2025) · Genome Medicine · doi:10.1186/s13073-025-01568-9 · Cited by 2
Complex glandular pattern is an aggressive morphology that predicts poor prognosis of pancreatic ductal adenocarcinoma
Kouchi, Y., Takano, S., Harada‐Kagitani, S., Shinomiya, Y., Yogi, N., Sakamoto, T., Mishima, T., Fugo, K., Kambe, M., Nagai, Y., et al. (2023) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2023.152110 · Cited by 2
Moving Beyond Chemotherapy for Pancreaticobiliary Tumors: Targeted and Immunotherapy Strategies
Allen, R. S., Halpern, N., Algaze, S. D., Golan, T., El-Khoueiry, A. B., & Shroff, R. T. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280901 · Cited by 2
The Role of Epigenetics in Pancreatic Ductal Adenocarcinoma
Roalsø, M. T. T., Hald, Ø. H., Ansari, D., Andersson, R. E., & Søreide, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_22 · Cited by 2
Personalized medicine and new therapeutic approach in the treatment of pancreatic cancer
Azari, H., Nazari, E., Jamialahmadi, H., Khalili‐Tanha, G., Maftooh, M., Hassanian, S. M., Ferns, G. A., Khazaei, M., & Avan, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-19142-8.00010-3 · Cited by 2
Induction chemotherapy in borderline (non-)resectable pancreatic cancer: a unique window of opportunity for understanding pancreatic cancer
Laethem, J. V. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.10.010 · Cited by 2
Spatial tumor immune heterogeneity facilitates subtype co-existence and therapy response via AP1 dichotomy in pancreatic cancerPreprint
Klein, L., Tu, M., Krebs, N., Urbach, L., Grimm, D. G., Latif, M. U., Penz, F., Chan, N., Aliar, K., Vyas, F., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.30.563552 · Cited by 2
WRAD core perturbation impairs DNA replication fidelity promoting immunoediting in pancreatic cancerPreprint
Citron, F., Ho, I.-L., Balestrieri, C., Liu, Z., Yen, E.-Y., Cecchetto, L., Perelli, L., Zhang, L., Castillo, L. A., Blazanin, N., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.21.619543 · Cited by 2
Using Molecular Subtyping of Pancreatic Ductal Adenocarcinoma for Multimodal Treatment Selection in Resectable Disease
Dima, S., Dumitraşcu, T., Popescu, I., & Duda, D. G. (2022) · Chirurgia · doi:10.21614/chirurgia.2772 · Cited by 1
Characteristics of KRAS WT pancreatic adenocarcinomas: results of a large French multicentric cohort
Trystram, N., Cros, J. F., Blons, H., Garinet, S., Nicolle, R., Corre, D. L., Zhao, S. L., Biagi, J. J., Harlé, A., Conroy, T., et al. (2025) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359251339939 · Cited by 1
Self-citation
Mutant p53 regulates reversible subtype plasticity in pancreatic cancer
Shin, J.-H., Kim, H.-R., & Roe, J. (2025) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-025-05945-w · Cited by 1
Multiomics Analysis of Nucleotide Metabolism Highlights the Important Role of Adenylate Kinase 4 in Pancreatic Cancer
Li, J., Yao, Y., Zhang, W., & Zhang, D. (2026) · Human Mutation · doi:10.1155/humu/7729933 · Cited by 1
Developmental and MAPK-responsive transcription factors regulate distinct malignant cell states and associated genetic dependencies in pancreatic cancer
Laise, P., Turunen, M., Curiel‐García, Á., Tomassoni, L., Maurer, H. C., Elyada, E., Schmierer, B., Worley, J., Kesner, J. S., Tan, X., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02714-8 · Cited by 22
Clonal heterogeneity in human pancreatic ductal adenocarcinoma and its impact on tumor progression
Kalfakakou, D., Cameron, D., Kawaler, E. A., Tsuda, M., Wang, L., Su, Q., Kim, S., Manolakos, E., Jing, X., Hajdu, C., et al. (2026) · Nature Genetics · doi:10.1038/s41588-026-02779-5 · Cited by 7
A shifting adversary: control of pancreatic cancer transcriptomic subtypes
David, C. J. (2022) · Journal of Cancer Metastasis and Treatment · doi:10.20517/2394-4722.2022.71 · Cited by 1
Introduction to Diagnosis and Treatment in Pancreatic Neoplasms
Ruiz, F. J. P. (2023) · Springer eBooks · doi:10.1007/978-3-031-21351-9_1 · Cited by 1
Vitamin D and pancreatic cancer
de Maturana, E. L., Zagorac, S., Malats, N., & Real, F. X. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91338-6.00042-2 · Cited by 1
Unlocking the Pancreatic Cancer Puzzle: Using Intermediate Cells to Target Treatment
Faraoni, E. Y., & McAllister, F. M. (2024) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-3295 · Cited by 1
A robust workflow to benchmark deconvolution of multi-omic data
Amblard, E., Bertrand, V., Barbot, H., Peña, L. M., Karkar, S., Chuffart, F., Ayadi, M., Baurès, A., Armenoult, L., Kermezli, Y., et al. (2025) · Genome biology · doi:10.1186/s13059-025-03897-9 · Cited by 1
Self-citation
New insights into tRNA-derived small RNAs in human digestive diseases
Liu, Y.-Q., Chen, F., Zhang, F., Ye, Y.-M., Su, Y., Liu, Y., & Leng, Y. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10393-7 · Cited by 1
Efficient Computation of High‐Dimensional Penalized Piecewise Constant Hazard Random Effects Models
Heiling, H., Rashid, N. U., Li, Q., Peng, X. L., Yeh, J. J., & Ibrahim, J. G. (2025) · Statistics in Medicine · doi:10.1002/sim.10311 · Cited by 1
Tumor-insular Complex in Neoadjuvant Treated Pancreatic Ductal Adenocarcinoma Is Associated With Higher Residual Tumor
González, I., Kang, L., Williams, G. A., Liu, J., DeNardo, D. G., Hawkins, W. G., & Chatterjee, D. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001454 · Cited by 1
PDAC Subtypes/Stratification
Brunton, H., Caligiuri, G., Inman, G. J., & Bailey, P. J. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_8 · Cited by 1
Molecular Subtyping of Pancreatic Cancer
Dreyer, S. B., Jamieson, N. B., Chang, D. K.-F., & Biankin, A. V. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_21 · Cited by 1
Multi-dimensional analyses identify genes of high priority for pancreatic cancer researchPreprint
Nwosu, Z. C., Giza, H., Nassif, M., Charlestin, V., Menjivar, R. E., Kim, D., Kemp, S. B., Steele, N. G., Hu, J., Hu, B., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.05.28.446056 · Cited by 1
An Investigation of Point Mutations Discovers Novel Genes and Their Corresponding Motifs in Pancreatic CancerPreprint
Ghareyazi, A., Mohseni, A., Dashti, H., Dehzangi, A., Rabiee, H. R., & Alinejad‐Rokny, H. (2021) · Preprints.org · doi:10.20944/preprints202108.0368.v1 · Cited by 1
Immunotherapy of solid tumors: multimodal imaging strategies for chimeric antigen receptor T cell tracking in the tumor microenvironment
Henze, J. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8758 · Cited by 1
Precision Cancer Medicine
Oh, G., Dhara, S., & Simeone, D. M. (2023) · Wiley eBooks · doi:10.1002/9781119876007.ch152 · Cited by 1
Favorable histo-molecular remodeling of pancreatic ductal adenocarcinoma after Total Neoadjuvant Therapy including Stereotactic Body RadiotherapyPreprint
Bouchart, C., Senar, O. A., Navez, J., Verset, L., Boisson, A., Hein, M., Stosic, K., Quertinmont, E., Tafciu, V., Zhao, S., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.04.30.591890 · Cited by 1
Self-citation
Defining and tracing subtypes of patient‐derived xenograft models in pancreatic ductal adenocarcinoma
Hyun, S., Han, Y., Moon, J. Y., Suh, Y., Yun, W., Kwon, W., Lee, J., Kim, D., Ku, J., Jang, J., et al. (2024) · 癌症：英文版 · doi:10.1002/cac2.12585 · Cited by 1
A Luminal–Basal Stratification of the Native Human Pancreatic Duct is Differentially Represented in Pancreatic CancersPreprint
den Bossche, J.-L. V., van der Vliet, M., Michiels, E., Senar, O. A., Lint, S. V., Madran, Z., Coolens, K., Brons, J., Nacher, M., Arsenijevic, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.14.632911 · Cited by 1
Self-citation
Lessons learned by features of pancreatic ductal adenocarcinoma and its tumor microenvironment
Blair, A. B., Groot, V. P., & He, J. P. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.01.32
The impact of molecular classification based on the transcriptome of pancreatic cancer: from bench to bedside
Deng, Y., Zhou, T., Wu, J., Chen, Y., Shen, C., Zeng, M., Chen, T., & Zhang, X. M. (2020) · Chinese Journal of Academic Radiology · doi:10.1007/s42058-020-00037-z
Subtypes of Pancreatic Adenocarcinoma
Ingenhoff, L., Häberle, L., & Esposito, I. (2020) · Molecular and translational medicine · doi:10.1007/978-3-030-49476-6_1
Anotação e caracterização de novos transcritos expressos no adenocarcinoma de pâncreas: RNAS não-codificadores longos associados a fenótipos tumorais e clínicos e formas alternativas de splicing
da Paixão, V. F. (2019) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.46.2019.tde-09032020-085211
Diversity Across the Pancreatic Ductal Adenocarcinoma Disease Spectrum Revealed by Network-Anchored Functional GenomicsPreprint
Rose, J. L., Srinivasan, S., Yao, W., Seth, S., Peoples, M. D., Machado, A. A., Li, C.-Y., Ho, I.-L., Lee, J. J., Guerrero, P. A., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.09.17.302034
Gene Targeting in Disease Networks
Glass, K., Quackenbush, J. F., Weighill, D. A., Platig, J., Yeh, J. J., & Guebila, M. B. (2024) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/bwz6-0071
TNM Staging for Pancreatic Adenocarcinoma
Roalsø, M. T. T., & Søreide, K. (2021) · Springer eBooks · doi:10.1007/978-3-030-53786-9_25
Basal-to-classical phenotypic switch of pancreatic cancer cells upon integration into the duodenal epitheliumPreprint
Bozóky, B., Moro, C. F., Strell, C., Ernberg, I. T., Székely, L., Gerling, M., & Bozóky, B. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.02.01.429212
Urokinase-type plasminogen activator receptor contributes to chemosensitivity and epithelial-to-mesenchymal transition in PDAC
Peng, L. (2020) · doi:10.53846/goediss-8274
Adjuvant Therapy in Pancreatic Cancer
Laethem, J. V. (2021) · doi:10.1002/9781119570097.ch61
New Pharmacological Approaches for Pancreatic Cancer Therapy
Gupta, V. K., Banerjee, S., & Saluja, A. K. (2021) · doi:10.1002/9781119570097.ch69
Cancer du pancréas
Buscail, L., Bournet, B., Carrère, N., Muscari, F., & Otal, P. (2021) · Elsevier eBooks · doi:10.1016/b978-2-294-77623-6.00006-7
Gastrointestinal, Hepatobiliary, and Pancreatic Tumors
Mohammad, M. K., & Chen, G. (2021) · Springer eBooks · doi:10.1007/978-3-030-73227-1_8
Refining pancreatic ductal adenocarcinoma molecular subtype and precision therapeutics with single-nucleus RNA-seq
He, L. (2021) · BMC Medicine · doi:10.1186/s12916-021-02052-y
Cancer du pancréas : épidémiologie, dépistage, diagnostic et bilan d'extension
Morgant, S., Munoz, L. A., Védié, A., Oumrani, S., Dermine, S., Hentic, O., Maire, F., Müller, N., Laurent, L., Cros, J. F., et al. (2021)
Self-citation
Overcoming Cisplatin Resistance in Pancreatic Cancer
Ewers, K. M. (2021) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8945
EZH2-GATA6 axis in Pancreatic ductal adenocarcinoma
Patil, S. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8223
GSK3β-mediated DNA damage repair in pancreatic cancer
Schmídt, G. (2021) · doi:10.53846/goediss-8509
Recent advances in understanding pancreatic cancer
Stott, M. C., Oldfield, L. S., Hale, J. J., Costello, E., & Halloran, C. M. (2022) · Faculty Reviews · doi:10.12703/r/11-10
High-dimensional deconstruction of pancreatic ductal adenocarcinoma identifies tumor microenvironmental communities associated with survivalPreprint
Storrs, E. P., Usmani, A., Chati, P., Sloan, I. H., Krasnick, B. A., Babbra, R. K., Harris, P. K. W., Qaium, F., Chatterjee, D., Wetzel, C., et al. (2022) · medRxiv · doi:10.1101/2022.04.29.22274376
Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
Giordano, M., Insilla, A. C., & Campani, D. (2020) · Encyclopedia of pathology · doi:10.1007/978-3-319-28845-1_5533-1
Faculty Opinions recommendation of Cell of origin influences pancreatic cancer subtype.
Sosa‐Pineda, B. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.739647870.793585324
TP53-status dependent oncogenic EZH2 Activity in Pancreatic Cancer
Versemann, L. (2022) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9359
The role of the ROBO 3 signaling pathway in pancreatic cancer plasticity
Krebs, N. (2022) · doi:10.53846/goediss-9412
Epithelial-stromal interactions in pancreatic adenocarcinoma: the role of stroma in disease progression
Kuznetsova, A. V., Попова, О. П., Анатольевич, А. Д., Ivanov, Y. V., Панченков, Д. Н., & Aa, I. (2022) · Russian Journal of Archive of Pathology · doi:10.17116/patol20228405165
Molecular Subtypes of Pancreatic Ductal Adenocarcinoma
Giordano, M., Insilla, A. C., & Campani, D. (2022) · Encyclopedia of pathology · doi:10.1007/978-3-030-62416-3_5533
Data from Prognostic Relevance of Pancreatic Adenocarcinoma Whole-Tumor Transcriptomic Subtypes and Components
Zhao, S., Nicolle, R., Augustin, J., Svrcek, M., de Mestier, L., Corre, D. L., Pietrasz, D., Caliez, O., Cros, J. F., Laurent‐Puig, P., et al. (2023) · doi:10.1158/1078-0432.c.6530900.v1
Self-citation
Data from A Clinically Applicable 24-Protein Model for Classifying Risk Subgroups in Pancreatic Ductal Adenocarcinomas using Multiple Reaction Monitoring-Mass Spectrometry
Son, M., Kim, H., Han, D., Kim, Y., Huh, I., Han, Y., Hong, S., Kwon, W., Kim, H., Jang, J., et al. (2023) · doi:10.1158/1078-0432.c.6530268.v1
Data from Cell of Origin Influences Pancreatic Cancer Subtype
Flowers, B. M., Xu, H., Mulligan, A. S., Hanson, K. J., Seoane, J. A., Vogel, H. S., Curtis, C. N., Wood, L. D., & Attardi, L. D. (2023) · doi:10.1158/2159-8290.c.6547895.v1
Data from PD-1/PD-L1–Associated Immunoarchitectural Patterns Stratify Pancreatic Cancer Patients into Prognostic/Predictive Subgroups
Karamitopoulou, E., Andreou, A. G., de Mortanges, A. P., Tinguely, M., Gloor, B., & Perren, A. A. (2023) · doi:10.1158/2326-6066.c.6550536.v1
Minute virus of mice is oncolytic for pancreatic cancer cells with mesenchymal phenotypePreprint
Garcin, P. O., Lulka, H., Dusetti, N., Vienne, M., Buscail, L., & Cordelier, P. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.11.536425
Engrailed-1 Promotes Pancreatic Cancer MetastasisPreprint
Xu, J., Roe, J., Lee, E., Tonelli, C., Somerville, T. D. D., Yao, M. A., Milazzo, J. P., Tiriac, H., Kolarzyk, A. M., Lee, E., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.10.536259
Time-lapse analyses of epithelial and mesenchymal pancreatic ductal adenocarcinoma sphere formation and spread on platesPreprint
Shichi, Y., Gomi, F., Hasegawa, Y., Nonaka, K., Shinji, S., Takahashi, K., & Ishiwata, T. (2023) · Research Square · doi:10.21203/rs.3.rs-2936452/v1
Pathology, Pathogenesis, and Molecular Characteristics
Chun, H. J., Park, S. J., Lim, Y. J., & Song, S. Y. (2023) · Springer eBooks · doi:10.1007/978-981-99-0815-8_49
Machine learning algorithm integrates bulk and single-cell transcriptome sequencing to reveal immune-related personalized therapy prediction features for pancreatic cancerPreprint
Zang, L., Zhang, B., Zhou, Y., Zhang, F., Tian, X., Tian, Z., Chen, D., & Miao, Q. (2023) · Research Square · doi:10.21203/rs.3.rs-3137621/v1
Data from Spectrum of Response to Platinum and PARP Inhibitors in Germline BRCA–Associated Pancreatic Cancer in the Clinical and Preclinical Setting
Stossel, C., Raitses‐Gurevich, M., Atias, D., Beller, T., Gorman, Y. G., Halperin, S., Peer, E., Denroche, R. E., Zhang, A. X. W., Notta, F., et al. (2023) · doi:10.1158/2159-8290.c.6742664
Molecular Subtypes and Clinical Applications
Bijlsma, M. F., & Bailey, P. J. (2023) · doi:10.1002/9781119876007.ch122
Quantification of Intratumoral Tissue Composition in Pancreatic Ductal Adenocarcinoma Using Multi-Phase DCE-MRI: A Multi-Center Study Integrating Digital Pathology and Medical ImagingPreprint
Xia, C., Qu, J., Jiao, Y., Lu, C.-Q., Zhao, B., Ge, R.-J., Qiu, Y., Guo, Y.-C., Yu, Q., Xia, T., et al. (2023) · SSRN Electronic Journal · doi:10.2139/ssrn.4587819
Dynamics of the microbiome in pancreatic cancer from inception to invasion
Pfisterer, N. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-10152
Neutrophil-derived complement factor P induces cytotoxicity in basal-like cells via caspase 3/7 activation in pancreatic cancerPreprint
Kishore, U., Varghese, P. M., Mangogna, A., Klein, L., Tu, M., Urbach, L., Qiu, M., Nicolle, R., Murugaiah, V., Beirag, N., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.10.28.564512
Self-citation
Associação entra a doença hepática gordurosa não alcoólica e o adenocarcinoma ductal de pâncreas
de Rezende, A. Q. M. (2021) · doi:10.47749/t/unicamp.2021.1165288
Echoendoscopic ultrasound pancreatic adenocarcinoma diagnosis and theranostic approach: should KRAS mutation research be recommended in everyday practice?
Béchade, D., Palmieri, L., Bonhomme, B., Pernot, S., Léna, J., Fonck, M., Pesqué, S., Boillet, G., Italiano, A., & Roseau, G. (2024) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848231224943
Pancreatic and Biliary Tract Cancers
Ney, A., Osei‐Bordom, D., García-Sampedro, A., Acedo, P., Fusai, G., Stott, M. C., Hopley, P. J., Patel, C., Oldfield, L. S., Greenhalf, W., et al. (2024) · Wiley eBooks · doi:10.1002/9781119756422.ch17
Additional file 3 of Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma
Yang, J., Lin, P., Yang, M., Liu, W. C., Fu, X., Liu, D., Tao, L., Huo, Y., Zhang, J., Hua, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520761
Additional file 14 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment
Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665357
Additional file 2 of Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma
Yang, J., Lin, P., Yang, M., Liu, W. C., Fu, X., Liu, D., Tao, L., Huo, Y., Zhang, J., Hua, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520758
Additional file 15 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment
Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665360
Additional file 16 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment
Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665363
Unveiling Fkbp7 as an Early Endoplasmic Reticulum Sentinel in Pancreatic Stellate Cell Activation, Collagen Remodelling and Tumor ProgressionPreprint
Quémerais, C., Jean, C., Brunel, A., Decaup, E., Labrousse, G., Audureau, H., Raffenne, J., Belhabib, I., Cros, J. F., Perraud, A., et al. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5064330
Self-citation
TRANSCRIPTOMIC ANALYSIS OF THE RELATIONSHIP BETWEEN PANCREATIC DUCTAL ADENOCARCINOMA STROMAL SUBTYPES AND NEURAL INVASIONPreprint
Yıldızhan, S. E., Demir, İ. E., Sever, E. A., Zeybek, D. K., Sezerman, O. U., & Ceyhan, G. O. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.13.632859
Glycation Stress–Driven Transcriptomic Signature Predicts Survival Benefit from Adjuvant Gemcitabine in Resectable Pancreatic CancerPreprint
Senar, O. A., Stosic, K., Bouchart, C., Navez, J., Tarfouss, J., Crake, R., Verset, L., Demetter, P., Mauduit, M., Conroy, T., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.07.663493
Self-citation
Importance of landscape exploration and progress in molecular therapies and precision medicine for pancreatic ductal adenocarcinoma
Hendi, M., Zhang, B., Mou, Y., & Cai, X.-J. (2025) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v17.i7.103337
Contemporary insights into the molecular mechanisms of development and genetic susceptibility to pancreatic cancer
Speridonova, A. D., Zaripova, A. R., Gilyazova, I. R., & Bermisheva, M. (2025) · Siberian Journal of Oncology · doi:10.21294/1814-4861-2025-24-3-149-161
Hypoxia-induced metastatic heterogeneity in pancreatic cancer
Gunasekaran, P. M., Wang, Q., Guseva, P., Chang, Y., Chauhan, R., Kley, A., Xu, M., Lee, G., Marshall, G., Roy, S. G., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-76143-w
Adaptive resistance to SHP2-based vertical RAS-pathway inhibition in pancreatic cancer involves multifaceted routes towards dedifferentiationPreprint
Chen, X., Keller, S. J., Das, T., Hafner, P., Alrawashdeh, A. Y., Jumaa, H., Chen, T., Besson, S., Norona, J., Schneider, M., et al. (2025) · medRxiv · doi:10.1101/2025.09.09.25335395
Microdissection: Insights and progress in the era of precision medicine
Golias, M., Krupova, Z., Defrenaix, P., Heymann, M., & Heymann, D. (2025) · Pathology - Research and Practice · doi:10.1016/j.prp.2025.156328
Urothelium marker UPK2 identifies aggressive colorectal cancers with distinct molecular and histological features
Äijälä, V. K., Härkönen, J., Sirniö, P., Mantere, T., Elomaa, H., Sirkiä, O., Kehusmaa, A., Karjalainen, H., Kastinen, M., Tapiainen, V. V., et al. (2025) · British Journal of Cancer · doi:10.1038/s41416-025-03300-1
p53 and YAP/TAZ-TEAD activities determine metaplastic heterogeneity in pancreatic cancerPreprint
Martin, C. P., Bang, S., Gomes, J. R., Sullivan, W. B., Liu, Y., Smith, M. D., Edwards, A. C., Der, C. J., & Morris, J. P. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.11.693520
Additional file 2 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment
Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665321
Additional file 2 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas
Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777848
Additional file 12 of High glucose-upregulated PD-L1 expression through RAS signaling-driven downregulation of PTRH1 leads to suppression of T cell cytotoxic function in tumor environment
Gao, C., Chen, J., Bai, J., Zhang, H., Tao, Y., Wu, S., Li, H., Wu, H., Shen, Q., & Yin, T. (2023) · Figshare · doi:10.6084/m9.figshare.23665351
Additional file 9 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas
Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777872
Additional file 1 of Integrated genomic and transcriptomic analysis reveals unique characteristics of hepatic metastases and pro-metastatic role of complement C1q in pancreatic ductal adenocarcinoma
Yang, J., Lin, P., Yang, M., Liu, W., Fu, X., Liu, D., Tao, L., Huo, Y., Zhang, J., Hua, R., et al. (2021) · Figshare · doi:10.6084/m9.figshare.13520755
Additional file 7 of Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis
Zhou, T., Xie, Y., Hou, X., Bai, W., Li, X., Liu, Z., Man, Q., Sun, J., Fu, D., Yan, J., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26586804
Additional file 28 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas
Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777929
Additional file 12 of Machine learning-based identification of biomarkers and drugs in immunologically cold and hot pancreatic adenocarcinomas
Ge, J., Ge, J., Tang, G., Xiong, D., Zhu, D., Ding, X., Zhou, X., & Sang, M. (2024) · Figshare · doi:10.6084/m9.figshare.26777881

Authors: Puleo, F., Nicolle, R., Blum, Y., Cros, J., Marisa, L., Demetter, P., Quertinmont, E., Svrcek, M., Elarouci, N., Iovanna, J., Franchimont, D., Verset, L., Galdon, M. G., Devière, J., de Reyniès, A., Laurent-Puig, P., Van Laethem, J.-L., Bachet, J.-B., & Maréchal, R.
Affiliations: Université Libre de Bruxelles (BE)
La Ligue Contre le Cancer (FR)
Erasmus Hospital (BE)
Hôpital Saint-Antoine (FR)
Centre National de la Recherche Scientifique (FR)
Pitié-Salpêtrière Hospital (FR)
Corresponding author: Puleo, Francesco
ORCID: Puleo, Francesco
Nicolle, Rémy
Blum, Yuna
Marisa, Laetitia
Demetter, Pieter
Quertinmont, Eric
Svrcek, Magali
Elarouci, Nabila
Iovanna, Juan
Franchimont, Denis
Verset, Laurine
Galdon, Maria Gomez
Laurent-Puig, Pierre
Bachet, Jean-Baptiste
Venue: Gastroenterology
Publisher: Elsevier BV
Published: 2018-12
Volume: 155
Issue: 6
Pages: 1999-2013.e3
ISSN: 0016-5085 (ISSN-L)
DOI: 10.1053/j.gastro.2018.08.033
OpenAlex: W2889433609
Cited by: 563
References: 34
Citations by year: 2026: 53 · 2025: 63 · 2024: 66 · 2023: 87 · 2022: 81 · 2021: 109 · 2020: 72 · 2019: 28 · 2018: 4
FWCI: 20.20
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Gastroenterology (publishedVersion)
PubMed (publishedVersion)
HAL (submittedVersion)
Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
Topics: Health Sciences › Medicine › Oncology › Pancreatic and Hepatic Oncology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
Keywords: pancreatic ductal adenocarcinoma, tumor subtypes, tumor microenvironment, gene expression profiling, formalin-fixed paraffin-embedded tissue, desmoplasia, basal-like subtype, classical subtype, overall survival, disease-free survival, independent component analysis, consensus clustering
MeSH terms: Progression-Free Survival, Adenocarcinoma, Adult, Aged, Aged, 80 and over, DNA, Neoplasm, Female, Humans, Male, Middle Aged, Pancreas, Prospective Studies, Regression Analysis, RNA, Neoplasm, Gene Expression, Proportional Hazards Models, Sequence Analysis, DNA, Disease-Free Survival, Carcinoma, Pancreatic Ductal, Pancreas, Exocrine, Tumor Microenvironment, Transcriptome, Acinar Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment Features

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks